OAR 855-019-0110
Definitions

In this Division of Rules:

(1)

“Clinical Pharmacy Agreement” means an agreement between a pharmacist or pharmacy and a health care organization or a physician that permits the pharmacist to engage in the practice of clinical pharmacy for the benefit of the patients of the health care organization or physician.

(2)

“Collaborative Drug Therapy Management (CDTM)” has the same meaning as defined in OAR 855-006-0005 (Definitions).

(3)

“Counseling” means an oral or other appropriate communication process between a pharmacist and a patient or a patient’s agent in which the pharmacist obtains information from the patient or patient’s agent, and, where appropriate, the patient’s pharmacy records, assesses that information and provides the patient or patient’s agent with professional advice regarding the safe and effective use of the drug or device for the purpose of assuring therapeutic appropriateness.

(4)

“Drug Regimen Review (DRR)” means the process conducted by a pharmacist who is consulting for a long-term-care facility or other institution, either prior to dispensing or at a later time, with the goal of ensuring that optimal patient outcomes are achieved from the drug therapy.

(5)

“Drug Utilization Review (DUR)” has the same meaning as defined in OAR 855-006-0005 (Definitions).

(6)

“Medication Therapy Management (MTM)” means a distinct service or group of services that is intended to optimize therapeutic outcomes for individual patients. Medication Therapy Management services are independent of, but can occur in conjunction with, the provision of a medication product.

(7)

“Practice of Clinical Pharmacy” means:

(a)

The health science discipline in which, in conjunction with the patient’s other practitioners, a pharmacist provides patient care to optimize medication therapy and to promote disease prevention and the patient’s health and wellness;

(b)

The provision of patient care services, including but not limited to post-diagnostic disease state management services; and

(c)

The practice of pharmacy by a pharmacist pursuant to a clinical pharmacy agreement.

(8)

“Practice of Pharmacy” is as defined in ORS 689.005 (Definitions).

Source: Rule 855-019-0110 — Definitions, https://secure.­sos.­state.­or.­us/oard/view.­action?ruleNumber=855-019-0110.

855–019–0100
Application 855–019–0110
Definitions 855–019–0120
Licensure 855–019–0122
Renewal of Licensure as a Pharmacist 855–019–0123
Liability Limitations for Volunteers 855–019–0125
Coaching from Board and Staff 855–019–0130
Licensure by Reciprocity 855–019–0140
NAPLEX Score Transfer 855–019–0150
Foreign Pharmacy Graduates 855–019–0160
Nuclear Pharmacists 855–019–0170
Reinstatement of License 855–019–0171
Reinstatement of a Revoked or Surrendered License 855–019–0200
General Responsibilities of a Pharmacist 855–019–0205
Duty to Report 855–019–0210
Duties of the Pharmacist Receiving a Prescription 855–019–0220
Drug Utilization Review (DUR) 855–019–0230
Counseling 855–019–0240
Consulting Pharmacist Practice 855–019–0250
Medication Therapy Management 855–019–0260
Collaborative Drug Therapy Management 855–019–0265
Administration of Drugs 855–019–0270
Immunization Qualifications 855–019–0280
Immunization Protocols, Policies and Procedures 855–019–0290
Immunization Record Keeping and Reporting 855–019–0300
Duties of a Pharmacist-in-Charge 855–019–0310
Grounds for Discipline 855–019–0400
Contraceptives - Purpose 855–019–0405
Contraceptives - Definitions 855–019–0410
Prescriptive Practice Consultation 855–019–0415
Contraceptive - Training Program 855–019–0425
Contraceptive - Procedural Mandates 855–019–0430
Contraceptive - Prohibited Practices 855–019–0435
Contraceptive - Records 855–019–0460
Naloxone - Delivery of Care and Prescribing 855–019–0470
Emergency Insulin
Last Updated

Jun. 8, 2021

Rule 855-019-0110’s source at or​.us